Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

8.150 -2.950 (-26.58%)
Official Closing Price Updated: 7:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
24 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday. 
Via Benzinga
News headline image
6 Stocks To Watch Amid Monkeypox Outbreak ↗
A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. 
Via Benzinga
News headline image
Stock Market Recap: This Week’s 5 Top Stories ↗
It's been a busy week for the stock market and we're going over all the latest news that investors need to know about with a recap! 
Via InvestorPlace
News headline image
Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments ↗
Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox. 
Via InvestorPlace
News headline image
71 Biggest Movers From Yesterday ↗
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... 
Via Benzinga
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... 
Via Benzinga
News headline image
What Is Monkeypox Virus That Is Spreading in Europe, US ↗
Monkeypox was first discovered in the late 1950s after cropping up among monkeys kept for research. Like smallpox and chickenpox, it is characterized by flu-like symptoms and pus-filled blisters and... 
Via Benzinga
News headline image
73 Biggest Movers From Yesterday ↗
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3% ↗
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 300 points on Monday. 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday. 
Via Benzinga
News headline image
41 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points ↗
U.S. stocks traded lower this morning, with the Nasdaq Composite adding more than 400 points on Friday. 
Via Benzinga
News headline image
7 High-Risk, High-Reward Small-Cap Stocks to Buy Now ↗
Many small-cap stocks in the S&P 600 Small Cap Index aren't big names, but they have the change of bringing big rewards. 
Via InvestorPlace
News headline image
Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco ↗
 
Via Benzinga
News headline image
Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements ↗
 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In... 
Via Benzinga
News headline image
Emergent BioSolutions: Q4 Earnings Insights ↗
Emergent BioSolutions (NYSE:EBS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
News headline image
Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada ↗
Canada has become the first country to fully approve Johnson & Johnson's (NYSE: JNJ) single-dose Covid-19 vaccine. According to a statement, regulators... 
Via Benzinga
News headline image
Why Emergent BioSolutions Popped by Over 4% Today ↗
The company has given 250 million reasons why investors should buy its stock. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 ↗
Upgrades For Nektar Therapeutics (NASDAQ: 
Via Benzinga
News headline image
92 Biggest Movers From Friday ↗
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... 
Via Benzinga
News headline image
See Why Emergent BioSolutions Stock Plunged 37% On Friday? ↗
After a fiasco surrounding the contamination of COVID-19 vaccine doses in its facilities, Emergent BioSolutions Inc's (NYSE: EBS) manufacturing deal with the US... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges 200 Points; Grid Dynamics Shares Spike Higher ↗
Toward the end of trading Friday, the Dow traded up 0.57% to 36,331.86 while the NASDAQ rose 0.20% to 15,972.41. The S&P also rose, gaining 0.40% to 4,698.70. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Chinook Therapeutics (NASDAQ:KDNY) shares increased by 28.75% to $15.76 during Friday's regular session. Trading volume for this security as of 12:30 EST is 1.... 
Via Benzinga
News headline image
Mid-Day Market Update: Gold Rises 1%; Deciphera Pharmaceuticals Shares Plummet ↗
Midway through trading Friday, the Dow traded up 0.65% to 36,358.13 while the NASDAQ rose 0.48% to 16,016.51. The S&P also rose, gaining 0.58% to 4,707.33. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
64 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.